Comparison of glecaprevir/pibrentasvir and sofosbuvir/ledipasvir as pangenotypic daa in patients with chronic hepatitis c in south korea: multicenter study

HEPATOLOGY(2022)

Cited 0|Views14
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined